Week 26 results from the PaTH Forward Open-Label Extension Trial Support TransCon PTH as a potential hormone replacement therapy for patients with hypoparathyroidism
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI